Prof. Dr. Eling de Bruin is a Lecturer at the Department of Health Sciences and Technology (D-HEST) at ETH Zurich. His research focuses on developing and evaluating exergame-based interventions targeting neurocognitive disorders, motor-cognitive training for aging populations, and stroke rehabilitation. He leads studies on personalized exergame protocols (e.g., PEMOCS framework) and their impact on cognitive function, gait recovery, and fall prevention. His work integrates wearable sensor technology, biofeedback systems, and clinical assessment tools to improve outcomes for chronic conditions like stroke, diabetes, and sarcopenia. Key areas include exergame design, hybrid training modalities, and biomarker validation (e.g., heart rate variability for neurocognitive screening). His research also explores sports biomechanics in youth athletes and injury prevention strategies for alpine skiers. Collaborative projects involve interdisciplinary teams from rehabilitation medicine, biomedical engineering, and computer science to create user-centered exergame solutions. Current initiatives emphasize home-based interventions and tele-rehabilitation to enhance accessibility for older adults and long-term care residents. Methodological contributions include validation of motor-cognitive assessment systems using virtual reality and inertial measurement units.
Dr. Philippe Campeau is an Associate Clinical Professor in the Department of Pediatrics at the Faculty of Medicine, Université de Montréal. He is affiliated with CHU Sainte-Justine, a major pediatric hospital in Montreal, Quebec, where he works in the Medical Genetics Service. His clinical and research work focuses on genetic disorders affecting children, particularly in the areas of skeletal development and neurogenetics. Dr. Campeau obtained his Doctorate in Medicine from Laval University in Quebec (1998-2003) followed by specialty training in medical genetics at McGill University (2003-2008). He completed postdoctoral training at Baylor College of Medicine (2008-2013), which further developed his expertise in genetic research methodologies. His primary research interests include bone dysplasias , skeletal dysplasias , epilepsy , and epigenetic diseases . Dr. Campeau's laboratory identifies disease-causing genes, deciphers disease pathophysiology, and works to improve the management of children affected by these conditions. His work encompasses exome analysis , functional studies with cell lines and mouse models , and investigations into urea cycle abnormalities . He has made significant contributions to understanding genetic causes of conditions such as Genitopatellar syndrome (KAT6B), osteopetrosis, dysosteosclerosis (SLC29A3), osteogenesis imperfecta, early-onset osteoporosis (WNT1), Yunis-Varón syndrome (FIG4), and DOORS syndrome (TBC1D24). Dr. Campeau's publication record demonstrates a strong trajectory in medical genetics research, with numerous high-impact publications spanning from fundamental genetic discovery to translational research. His work spans skeletal disorders, neurodevelopmental conditions, and epigenetic mechanisms. Recent publications indicate an expanding focus on chromatin modifiers, DNA methylation patterns, and spliceosome function in neurodevelopmental conditions, reflecting the evolution of his research interests toward more complex molecular mechanisms. Dr. Campeau has received several research grants in recent years (6 starting in 2014) from organizations including the Fonds de la recherche en santé du Québec, Canadian Institutes of Health Research, and Fondation Grand Défi Pierre Lavoie. While specific students are not mentioned in the available information, as a clinical professor, he mentors medical students, residents, and research trainees in the Department of Pediatrics. His research is conducted as part of the 'Musculoskeletal Diseases and Rehabilitation' axis at CHU Sainte-Justine Research Center, where he collaborates with international research teams to identify disease-causing genes and develop better management strategies for children with genetic disorders.
Dr Andrea Greve is a Lecturer in the Department of Psychology at the University of Cambridge . Her research focuses on cognitive processes related to memory, prediction error, and learning mechanisms. Key areas of interest include declarative memory formation, semantic predictions, and the influence of novelty on memory retention. She has explored topics such as word learning in variable-choice paradigms, the role of hippocampal lesions in memory binding, and predictive coding in neuroimaging contexts. Her work integrates experimental psychology with neuroscience methodologies, particularly leveraging neuroimaging techniques to investigate memory systems. Notable contributions include studies on false memory effects, the nonmonotonic relationship between object-location memory and expectedness, and the impact of prior knowledge on memory encoding. Dr. Greve has also contributed to methodological advancements, such as improved MRI anonymization for MEG coregistration. While her research spans multiple decades, recent efforts (2023–2025) emphasize predictive frameworks and their applications in understanding cognitive phenomena like semantic surprise and episodic memory formation. Her findings challenge traditional assumptions about fast mapping in adults and highlight the importance of integrating computational models with empirical data. Dr. Greve collaborates extensively with neuroimaging and cognitive science teams, contributing to interdisciplinary projects that bridge theoretical and applied research in memory systems. Her work maintains a strong focus on methodological rigor, particularly in experimental design and data interpretation.
Zsofia Zavecz is a Research Associate at the University of Cambridge Department of Psychology. Her work focuses on the neurophysiological mechanisms underlying sleep and memory consolidation, with particular emphasis on electrophysiological correlates of lucid dreaming and sleep-dependent learning. Research highlights include: Investigation of EEG functional connectivity during statistical learning Study of transcranial stimulation effects on probabilistic learning Analysis of sleep restriction impacts on hormonal regulation Exploration of cognitive reserve mechanisms in sleep disorders Her neuroscientific investigations span procedural memory systems, neural oscillations, and cross-population studies in both healthy individuals and pediatric sleep-disordered breathing patients.
Lars Nyberg is a Professor of Neuroscience at Umeå University's Medical Faculty and Director of the Umeå Centre for Functional Brain Imaging (UFBI) since 2001. He has held concurrent roles as Guest Professor in Bergen and Oslo, Norway, and led the Wallenberg Centre for Molecular Medicine (WCMM) from 2019. His academic leadership includes directing major initiatives like the EU-funded Lifebrain project (2017–2022) and holding the Torsten & Ragnar Söderberg Research Professorship in Medicine (2012–2017). Education: PhD in Psychology (1993) and Docent (1996) from Umeå University, with postdoctoral training at the Rotman Research Institute, Toronto. His research focuses on neuroimaging techniques (MRI/PET), dopamine systems, working memory, aging, and episodic memory. Key contributions include linking dopamine receptor availability to cognitive decline and demonstrating brain maintenance mechanisms in aging. Research Interests: Neuroimaging of memory systems, dopamine's role in cognition, aging-related brain changes, and cognitive reserve. Grants: EU Horizon 2020 (Lifebrain, €10M), KA Wallenberg Scholarships (2009, 2016), Swedish Research Council funding for COBRA (2013–2017). His awards include Royal Swedish Academy of Sciences membership (2008), Mångbergs Prize in Neural Sciences (2008), and multiple Wallenberg grants. Nyberg has supervised 27 PhD students and 11 postdocs, advancing translational neuroscience and aging research through interdisciplinary teams at UFBI and WCMM.
Frank Russo is a Professor in the Department of Psychology at Toronto Metropolitan University, where he holds the NSERC-Sonova Senior Research Chair in Auditory Cognitive Neuroscience. He leads the Science of Music Auditory Research and Technology (SMART) Lab and holds affiliate and adjunct positions at the University Health Network and the University of Toronto, respectively. Research Interests: Dr. Russo's work lies at the intersection of auditory cognitive neuroscience, music psychology, and rehabilitation. His research explores how humans perceive music and speech, particularly under challenging conditions such as hearing loss or non-native accents. He investigates the cognitive and neural mechanisms of listening effort, emotional speech processing, and the social and therapeutic benefits of music, especially through community choirs and digital interventions. Publication Trends: His recent publications emphasize objective measurement of listening effort using functional near-infrared spectroscopy (fNIRS), music-based interventions for Parkinson’s disease and dementia, vocal and emotional responses to singing, and multisensory integration in beat perception. The work is highly translational, bridging basic cognitive neuroscience with clinical and community applications. Scientific Awards and Honors: NSERC-Sonova Senior Research Chair in Auditory Cognitive Neuroscience Fellow of the Canadian Psychological Association Fellow of Massey College Fellow of the Canadian Society for Brain, Behavior and Cognitive Science Past President of the Canadian Acoustical Association Advising and Grants: Dr. Russo actively mentors students and researchers, as evidenced by his co-authorship with numerous junior colleagues. He has secured major funding through NSERC and industry partnerships, enabling the development of impactful technologies such as hearing aid algorithms, sensory substitution systems, and digital therapeutics. His SingWell project fosters collaboration across academic, clinical, and community sectors. Labs and Teams: He directs the SMART Lab at Toronto Metropolitan University, a hub for interdisciplinary research on music, hearing, and cognition. The lab collaborates extensively with KITE Research Institute, Rehabilitation Sciences at the University of Toronto, and various community organizations focused on aging, hearing loss, and neurodegenerative conditions.
Professor Moritz Rossner serves as Head of the Department of Molecular and Behavioral Neurobiology at the Department of Psychiatry and Psychotherapy, Faculty of Medicine, Ludwig-Maximilians-Universität München (LMU). His research integrates molecular and behavioral approaches to understand the neurobiological underpinnings of psychiatric disorders, particularly schizophrenia and bipolar disorder. Rossner's research interests focus on molecular neurobiology and behavioral analysis using mouse models. His laboratory employs advanced techniques including mouse genetics , behavioral phenotyping , biosensors , next-generation sequencing , and transcriptomics to investigate psychiatric risk genes and pathways. His work bridges cellular and molecular mechanisms with behavioral outcomes, particularly in schizophrenia and bipolar disorder research. Analysis of Rossner's 15 most recent publications (2025) reveals a strong focus on precision psychiatry , neuroimaging biomarkers , and genetic mechanisms underlying psychiatric disorders. His research increasingly incorporates multimodal approaches combining neuroimaging, genomics, and clinical phenotyping to develop biologically informed diagnostic and treatment frameworks. Key themes include blood-brain barrier dysfunction in schizophrenia, inflammatory contributions to symptom severity, and pathway-specific polygenic scores for treatment prediction. Rossner leads the Molecular & Behavioural Neurobiology working group at LMU's Department of Psychiatry and Psychotherapy, which includes specialized units like the Mouse Behavioral Unit. His research program appears well-funded through multiple collaborative projects focused on understanding the molecular basis of psychiatric disorders and developing novel therapeutic approaches.
Dr. Catherine Verrier Piersol is Professor and Chair of the Department of Occupational Therapy at Thomas Jefferson University's Jefferson College of Rehabilitation Sciences, where she also directs Jefferson Elder Care. She holds a PhD from Virginia Commonwealth University, an MS from Boston University, and a BS from Tufts University. Her research focuses on neurocognitive disorders (especially dementia), caregiver support interventions, aging-in-place strategies, and translating evidence-based occupational therapy into real-world settings. Key themes include person-environment-occupation fit, functional capacity appraisal, and non-pharmacological dementia care. Recent publications emphasize practical implementations of dementia care models, technology-enabled aging solutions, and pandemic-era adaptations in long-term care. Methodologies feature randomized trials, mixed-methods designs, and economic evaluations. Awards and honors include: Fellow, National Academies of Practice (2024) Fellow, American Occupational Therapy Association (2015) Stephen Heater Award for Outstanding Achievement (2013) Jeanette Blair Writer’s Award (2013) Multiple service awards from state/national OT associations (1998–2011) She leads Jefferson Elder Care, developing programs to enhance occupational therapy for older adults. Certifications include National Board OT licensure and Pennsylvania/New Jersey practice credentials.
Dr. Steven P. Miller is a Professor and Head of the Department of Pediatrics at the University of British Columbia's Faculty of Medicine. He also serves as the Chief of Pediatric Medicine at BC Children's Hospital & Sunny Hill Health Centre under the Provincial Health Services Authority. Additionally, he holds the Hudson Family Hospital Chair in Pediatric Medicine and is an Investigator at BC Children's Hospital. Dr. Miller's research focuses on neonatal neurology, particularly brain development and injury in newborns. His work utilizes advanced magnetic resonance techniques and bedside brain monitoring to understand how a baby's critical care experience influences their risk of brain injury and developmental trajectory. His research areas include birth defects, concussion, preterm labor, and steroid effects on neonatal brain development. Analysis of Dr. Miller's recent publications reveals a strong emphasis on understanding the relationship between neonatal pain exposure, analgesia, and brain development in preterm infants. His work also extensively examines neurodevelopmental outcomes in infants with congenital heart disease, exploring how fetal hemodynamics, surgical interventions, and brain imaging findings correlate with long-term cognitive outcomes. A significant portion of his research investigates the impact of socioeconomic status on brain development and neurocognitive outcomes in preterm infants. Dr. Miller is actively involved in graduate education, supervising students in Neuroscience and Women+ and Children's Health Sciences programs at UBC. His research group, part of the Brain, Behaviour & Development Research Theme and the Neurodevelopmental and Neurological Disorders Visualizing the Brain Research Group, has published extensively in top-tier journals across neurology, pediatrics, and neuroscience.
Professor Alan Winston serves as Professor of Genito-Urinary Medicine within the Department of Infectious Disease at Imperial College London's Faculty of Medicine. He concurrently holds a Consultant Physician position at St. Mary's Hospital, London, where he directs the HIV and GU clinical trials unit managing over 20 active studies. His clinical and academic work bridges patient care with cutting-edge research in HIV comorbidities. Winston qualified from Glasgow University and completed specialized training in general medicine and HIV care across the UK and Australia. This foundation supports his current focus on non-infectious complications in the modern antiretroviral era, particularly neurological and mental health aspects. His research prominently explores central nervous system complications in HIV, cognitive impairment mechanisms, and mental health disparities including depression and anxiety. He investigates multimorbidity patterns in aging HIV populations and develops person-centered approaches to reduce stigma. His work integrates clinical trials, cohort studies like POPPY, and mixed-methods research to address quality-of-life challenges beyond viral suppression. Analysis of his 2024-2025 publications reveals three dominant trends: (1) neurocognitive effects of specific antiretrovirals (dolutegravir, bictegravir), (2) psychosocial determinants of cognitive performance, and (3) systemic barriers in mental healthcare access for HIV patients. The POPPY cohort study serves as a critical data source across multiple publications examining aging, polypharmacy, and multimorbidity. Winston leads the POPPY study tracking comorbidities in HIV-positive individuals over time and directs the St. Mary's clinical trials unit conducting therapeutic research. His team includes clinical project managers, trials coordinators, and research staff like PhD candidate Merle Henderson. While specific grants aren't detailed, his management of 20+ concurrent studies indicates substantial research funding from sources including European AIDS Clinical Society collaborations. His laboratory and clinical operations are centered at the Winston Churchill Wing of St Mary's Campus, with affiliations to the Section of Virology and St Mary's Clinical Trials Centre. He contributes to European guideline development, notably statin use recommendations for cardiovascular prevention in HIV patients.
Michael G. Wheaton is an Assistant Professor of Psychology at Barnard College, specializing in the psychopathology and treatment of obsessive-compulsive disorder (OCD) and related conditions. He joined Barnard's faculty in 2017 after postdoctoral work at the New York State Psychiatric Institute and teaching roles at Yeshiva University. Education: B.A. from Cornell University; M.A. and Ph.D. from the University of North Carolina at Chapel Hill. Professional Affiliations: Association for Behavioral and Cognitive Therapies (ABCT), International OCD Foundation (IOCDF), Anxiety and Depression Association of America (ADAA). His research integrates cognitive-behavioral therapy (CBT) with neurobiological and psychological frameworks, emphasizing treatment outcomes for OCD, hoarding disorder, and anxiety-related conditions. Recent work explores the therapeutic working alliance, distress tolerance, and the impact of the COVID-19 pandemic on OCD symptoms. He has contributed to advancements in exposure and response prevention (ERP) and pharmacotherapy augmentation for OCD. Scientific Awards: Recognized among the top 2% of cited authors globally. Recipient of 2024 Barnard faculty grants and awards. He teaches undergraduate courses in Abnormal Psychology and Introduction to Clinical Psychology . His collaborations with Barnard graduates and institutions highlight his engagement with student research and public mental health discourse, including media contributions to Business Insider and Time .
Inna Fishman, Ph.D., is a Research Associate Professor at San Diego State University's Department of Psychology within the College of Sciences. Her research investigates brain network organization in autism spectrum disorder (ASD) using multimodal MRI techniques, focusing on developmental trajectories from toddlerhood to adulthood. She directs studies on sensory processing, socioeconomic influences, and neural connectivity patterns in ASD. Research Focus: Dr. Fishman's work bridges social neuroscience and clinical neuropsychology, examining: Early biomarkers of ASD via functional/diffusion MRI Impact of bilingualism and socioeconomic factors on neurodevelopment Sleep disorders and sensory sensitivities in autistic children Aging-related neural changes in adults with ASD Publication Trends: Her recent articles (2021-2025) emphasize: 1) Advanced neuroimaging of ASD across lifespan stages, 2) Machine learning applications for diagnostics, 3) Socioeconomic and environmental modulators of brain development, and 4) Sleep/auditory processing comorbidities. Student Advising & Grants: She mentors doctoral candidates (Lindsay Olson, Jiwandeep Kohli, Bosi Chen) and leads NIH-funded projects including a clinical psychology fellowship for autism evaluation across ages. Laboratory Affiliation: Dr. Fishman co-directs the Brain Development Imaging Laboratories (BDIL), which investigates ASD manifestations through behavioral and neuroimaging approaches.
Susanne M. Jaeggi is a Professor of Psychology at Northeastern University, with additional affiliations in the Bouve College of Health Sciences and the College of Arts, Media, and Design. Her research focuses on cognitive training, executive functions, and individual differences in cognition across the lifespan. She holds PhDs in Cognitive Psychology and Neuroscience from the University of Bern (Switzerland), and completed postdoctoral work in Cognitive Neuroscience at the University of Michigan. Her work has been funded by NIH, NSF, IES, ONR, and the Advanced Education Research and Development Fund (AERDF). She leads the Working Memory & Plasticity Lab , which develops interventions to improve working memory and executive functions, and co-leads the Brain Game Center for Mental Fitness and Well-Being , creating evidence-based brain fitness tools. Jaeggi’s research emphasizes understanding mechanisms of cognitive improvement through training, including neuroplasticity and individual variability. Key areas include cognitive aging interventions, gamification, sensory-cognitive interactions, and the impact of socioeconomic factors on academic achievement. Her work integrates behavioral experiments, neuroimaging, and digital health technologies to address real-world challenges in education and healthcare. Recent studies explore music/art-based interventions, brain stimulation (e.g., tDCS), and scalable cognitive assessments. Collaborations span disciplines, with publications addressing topics like neural correlates of training, motivational features in interventions, and cross-modal perception. Her labs emphasize translating findings into public-facing tools, such as freely accessible brain fitness apps. Current projects include optimizing interventions for ADHD populations and leveraging digital platforms for global mental fitness.
Marshall J. Glesby is a Professor at Weill Cornell Medical College, affiliated with both the Department of Medicine and Population Health Sciences. His career spans over three decades, focusing on HIV pathogenesis, aging-related complications, and co-infections. He holds a Ph.D. from Johns Hopkins University School of Hygiene and Public Health (1997), an M.D. from Johns Hopkins University School of Medicine (1989), and a B.Sc. from McGill University (1985). Research Interests: His work integrates HIV, immunology, and public health, emphasizing co-infections, metabolic disorders, and cardiovascular complications. Recent studies explore geriatric syndromes, epigenetic aging, and biomarkers like extracellular vesicles in Long COVID and Alzheimer's disease. He leads clinical trials on Mpox severity scoring and HIV-kidney transplantation. Grants and Collaborations: Dr. Glesby is a key investigator for NIH-funded projects, including PORTENT (NIAID) and STRIVE (NIAID). He contributes to global HIV research networks like INSIGHT and ACTG, with subawards from the National Institute of Child Health & Human Development and NHLBI. External Relationships: He serves as a consultant for UpToDate, Inc., and collaborates with organizations such as the Northeast/Caribbean AIDS Education and Training Centers.
Dimitris N Kiosses serves as Professor of Psychology in Psychiatry at Weill Cornell Medical College's School of Medicine since 2021. His academic affiliations center within the Department of Psychiatry with a focus on geriatric mental health services and research. His educational background includes a B.S. from Tufts University (1992), M.A. (1994), and Ph.D. (1999) from Adelphi University, establishing his foundation in clinical psychology with specialization in geriatric populations. Dr. Kiosses' research primarily investigates late-life depression, suicide prevention in older adults, and cognitive-behavioral interventions for comorbid conditions. His work emphasizes Problem Adaptation Therapy (PATH) development and implementation, particularly for depressed elders with cognitive impairment or chronic pain. Recent publications demonstrate growing focus on digital mental health tools, ecological momentary assessment, and international applications of geriatric interventions. His studies frequently examine emotion regulation mechanisms, neurocognitive correlates of depression, and implementation science approaches for real-world settings. Analysis of his 15 most recent publications reveals consistent thematic progression toward transdiagnostic approaches for late-life mental health, with increasing emphasis on technology-enabled interventions, cross-cultural adaptation, and precision medicine applications. The work spans clinical trials, implementation studies, and neurobiological investigations, predominantly targeting depression-suicide pathways in aging populations. Dr. Kiosses maintains active research mentorship through his leadership of multiple NIH-funded projects. His grant portfolio demonstrates particular strength in securing R01-level funding from NIMH and NIA for innovative geriatric mental health interventions. As Principal Investigator, he directs the Problem Adaptation Therapy research program which has evolved from home-based depression treatment (PATH) to specialized adaptations including PATH-Pain and suicide prevention applications. His work increasingly incorporates digital health components and focuses on implementation within primary care and community settings.
